Matteo Perucchini

One of the CHR founders and Board directors, Matteo is an experienced and outcomes-oriented CEO with broad commercial experience across several high-performing businesses. Matteo’s expertise encompasses clinical and commercial development strategies at both the product and franchise levels, brand plan development, and life-cycle management.

Prior to CHR, Matteo had a varied career involving both consulting and entrepreneurship, working out of the UK, Italy, and Singapore, leading global teams and projects across a wide range of therapeutic areas.

Matteo received his Ph.D. from the University of Edinburgh and holds an MPhil in Bioscience Enterprise from the University of Cambridge.